Investigating Indirect Mechanism of Neuroprotection of Tecfidera® (Dimethyl Fumarate) in RRMS and Progressive Patients
Status: Active, no longer recruiting
Phase of Trial: Phase IV
Latest Information Update: 27 Mar 2018
Price : $35 *
At a glance
- Drugs Dimethyl fumarate (Primary)
- Indications Multiple sclerosis
- Focus Pharmacodynamics; Therapeutic Use
- 20 Mar 2018 Planned End Date changed from 1 Dec 2017 to 1 Dec 2018.
- 20 Mar 2018 Planned primary completion date changed from 1 Dec 2017 to 1 Dec 2018.
- 03 Apr 2017 New trial record